Catalyst Wire Dossier Catalyst Wire Dossier

QUZYTTIR

cetirizine hydrochloride · TerSera Therapeutics LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for QUZYTTIR, covering 2019-10-04 to 2025-07-28. Get the full timeline:

Most recent: FDA Approved: QUZYTTIR — Supplemental Application (TerSera Therapeutics LLC)

See pricing